Detection of human papillomavirus DNa in PUVA-associated non-melanoma skin cancers

Journal of Investigative Dermatology

Volumn 111, Issue 1, 1998, Pages 123-127

  Harwood, Catherine A ^a,c   Spink, Patricia J ^a   Surentheran, T ^a   Leigh, Irene M ^a   Hawke, John L M ^b   Proby, Charlotte M ^a   Breuer, Judith ^a   McGregor, Jane M ^a,b  

^a ROYAL LONDON HOSPITAL   (United Kingdom)

^b ST THOMAS HOSPITAL   (United Kingdom)

^c QUEEN MARY UNIVERSITY OF LONDON   (United Kingdom)

Author keywords

Immunosuppression; Photochemotherapy; Viral carcinogenesis

Indexed keywords

CAPSID PROTEIN; CYCLOSPORIN; ETRETIN; ETRETINATE; METHOTREXATE; PSORALEN;

ADULT; AGED; ARTICLE; CANCER RISK; CLINICAL ARTICLE; DNA DETERMINATION; DOSE RESPONSE; FEMALE; HUMAN; HUMAN CELL; HUMAN TISSUE; KIDNEY TRANSPLANTATION; MALE; NUCLEOTIDE SEQUENCE; PAPILLOMA VIRUS; PRIORITY JOURNAL; PUVA; SKIN CANCER; ULTRAVIOLET A RADIATION; VIRUS DETECTION; VIRUS TYPING;

EID: 0031803758     PISSN: 0022202X     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1523-1747.1998.00240.x     Document Type: Article

References (40)

1. Acalay J, Ullrich SE, Kripke ML: Local suppression of contact hypersensitivity in mice by a monofunctional psoralen plus UVA radiation. Photochem Photobiol 50:217-220, 1989
2. Barr B, Benton E, McLaren K, Bunney MH, Smith IW, Blessing K, Hunter JA; Human papillomavirus infection and skin cancer in renal allograft recipients. Lancet 1:124-129, 1989
3. Bayle-Lebey P, Labadies P, Basset-Seguin N, Bazex J: Carcinomes cutanes et papillomavirus 5, Revelation lors d'une photochimiotherapie UVA prolongee. Ann Dermatol Venereol 121:496-498, 1994
4. Berkhout RJM, Tieben LM, Smits HL, Bouwes-Bavinck JN, Vermeer BJ. ter Schegget J: Detection and typing of epidermodysplasia verruciformis-associated human papillomavirus types in cutaneous cancers from renal transplant recipients. J Clin Microbiol 33:690-695, 1995
5. Boxman ILA, Berkhout RJM, Mulder LHC, Wolkers MC, Bouwes Bavinck JN, Vermeer BJ, ter Schegget J: Detection of human papillomavirus DNA in plucked hairs from renal transplant recipients and healthy volunteers J Invest Dermatol 108:712-715, 1997
6. Bruynzeel I, Bergman W, Hartevelt HM, Van Kenter CC, de Velde EA, Schothorst AA, Suurmond D: "High single-dose" European PUVA regimen also causes an excess of non-melanoma skin cancer Br J Dermatol 124:49-55, 1991
7. Chan SY, Delius H, Halpern AL, Bernard H-U: Analysis of genomic sequences of 95 papillomavirus types; uniting typing, phylogeny and taxonomy. J Virol 69:3074-3083, 1995
8. Chuang TY, Heinrich LA, Schultz MD, Reizner GT, Kumm RC, Cripps DJ: PUVA and skin cancer. A historical cohort study on 492 patients. J Am Aaid Dermatol 26:173-177, 1992
9. Eliezri YD, Silverstein SJ, Nuovo GJ: Occurrence of human papillomavirus type 16 DNA in cutaneous squamous and basal cell neoplasms. J. Am Acad Dermatol 23:836-838, 1990
10. Forman AB, Roenigk HH, Caro WA, Magid ML: Long-term follow-up of skin cancer in the PUVA -48 co-operative study. Arch Dermatol 125:515-519, 1989
11. Glover MT, Proby CM, Leigh IM: Skin cancer in renal transplant patients. Cancer Bull 45:220-224, 1993
12. Hirt L, Hirsch-Behnam A, de Villiers E-M: Nucleotide sequence of human papillomavirus (HPV) type 41; an unusual HPV type without typical E2 binding site consensus sequence. Virus Res 18:179-190, 1990
13. de Jong-Tieben LM, Berkhout RJM, Smits HL, Bouwes Bavinck JN, Vermeer BJ, van der Woude FJ, ter Schegget J: High frequency of detection of epidermodysplasia verruciformis-associated human papillomavirus DNA in biopsies from malignant and premalignant skin lesions from transplant recipients. J Invest Dermatol 105:367-371, 1995
14. Kripke ML, Morison WL, Parrish JA: Systemic suppression of contact hypersensitivity in mice by psoralen plus UVA radiation (PUVA). J Invest Dermatol 81:87-92, 1983
15. Lever LR, Farr PM: Skin cancers or premalignant lesions occur in half of high-dose PUVA patients. Br J Dermatol 131:215-219, 1994
16. Lindelöf B, Sigurgeirsson B, Tegner E, et al: PUVA and cancer: a large-scale epidemiological study. Lancet 338:91-93, 1991
17. Lutzner MA, Orth G, Dutronquay V, Ducasse M-F, Kreis H, Crosnier J: Detection of human papillomavirus type 5 in skin cancers of an immunosuppressed renal allograti recipient, Lancet 2:422-424, 1983
18. Majewski S, Jablonska S: Epidermodysplasia verruciformis as a model of human papillomavirus-induced genetic cancer of the skin. Arch Dermatol 131:1312-1318. 1995
19. Manos MM, Ting Y, Wright DK, Lewis AJ, Broker TR, Wolinsky SM: The use of polymerase chain reaction amplification for the detection of genital human papillomaviruses. Cancer Cells 7:209-214, 1989
20. McGregor JM, Proby CM: The role of papillomaviruses in human non- melanoma skin cancer. In: Leigh IM, Newton Bishop JA, Kripke ML (eds.). Cancer Surveys. Vol. 26: Skin Cancer. Cold Spring Harbour Press, New York. 1996, pp. 219-236
21. Morison WL, Wimberley J, Parrish HA, Bloch KJ: Abnormal lymphocyte function following long-term PUVA therapy for psoriasis. Br J Dermatol 108:445-450, 1983
22. Moy RL, Eliezre YD, Nuovo GJ, Zitelli JA, Bennett RG, Silverstein S: Human papillomavirus type 16 DNA in periungual squamous cell carcinomas. J Am Med Assoc 261:2669-2673, 1989
23. Nataraj AJ, Wolf P, Cerroni L, Ananthaswarmy HN: p53 mutation in squamous cell carcinomas from psoriasis patients treated with psoralen + UVA (PUVA). J Invest Dermatol 109:238-243, 1997
24. Proby C, Storey A, McGregor J. Leigh I: Does human papillomavirus infection play a role in non-melanoma skin cancer? Papillomavirus Report 7:53-60, 1996
25. Rubben A, Baron JM, Gussendorf-Conen E-I: Demonstration of human papillomavirus type 16-related DNA and absence of detectable p53 gene mutations in widespread cutaneous squamous cell carcinomas after oral psoralen with UV-A treatment. Arch Dermatol 132:1257-1259, 1996
26. Saiki RK, Scharf S, Faloona F: Enzymatic amplification of β-globin genomic sequence and restriction site analysis for diagnosis of sickle cell anaemia. Science 230:1350-1354, 1985
27. Sambrook J, Fritsch EF, Maniatis T: Molecular Cloning. A Laboratory Manual. Cold Spring Harbour Press, New York, 1982
28. Shamanin V, Delius H, de Villiers E-M: Development of a broad spectrum PCR assay for papillomaviruses and its application in screening lung cancer biopsies. J Gen Virol 75:1149-1156, 1994a
29. Shamanin V, Glover M, Rausch C, Proby C, Leigh IM, Zur Hausen H, de Villiers E-M: Specific types of human papillomavirus found in benign proliferations and carcinomas of the skin in immunosuppressed patients. Gancer Res 54:4610-4613, 1994b
30. Shamanin V, zur Hausen H, Lavergne D, et al: Human papillomavirus infections in non-melanoma skin cancers from renal transplant recipients and non-immunosuppressed patients. J Natl Cancer Inst 88:802-811, 1996
31. Snijders PJF, Van den Brule AJC, Schrijnemakers HFJ: The use of general primers in the polymerase chain reaction permits the detection of a broad spectrum of HPV genotypes. J Gen Virol 71:173-181, 1990
32. Stark LA, Arends MJ, McLaren KM, Benton EC, Shahidullah H, Hunter JAA, Bird CC: Prevalence of human papillomavirus DNA in cutaneous neoplasms from renal allograft recipients supports a possible viral role in tumour promotion, Br J Cancer 69:222-229, 1994
33. Stern RS, Lange R: Non-melanoma skin cancer occurring in patients treated with PUVA five to ten years after first treatment. J Invest Dermatol 91:120-124, 1988
34. Stern RS, Thibodeau LA, Kleinerman RA, Parrish JA, Fitzpatrick TB: Risk of cutameous carcinoma in patients treated with oral methoxsalen photochemotherapy for psoriasis. N Engl J Med 300:809-813, 1979
35. Strauss GH, Bridges BA, Greaves M, Hall-Smith P, Price M, Vell-Briffa D: Inhibition of delays hypersensitivity reaction in skin (DNCB test) by 8-methoxypsoralen photochemotherapy. Possible basis for pseudo-promoting action in skin carcinogenesis? Lancet 2:556-559, 1980
36. Studniberg HM, Weller P: PUVA, UVB, Psoriasis and nonmelanoma skin cancer. J Am Acad Dermatol 29:1013-1022, 1993
37. Ullrich SE: Systemic immunosuppression of cell-mediated immune reactions by a monofunctional psoralen plus ultraviolet A radiation. Photodermatol Photoimmunol Photomed 8:116-122, 1991
38. de Villiers E-M: Human pathogenic papillomavirus types: un update. In: zur Hausen H (ed.). Current Topics in Microbiology Immunology. Springer-Verlag. New York, 186:1-12, 1994
39. Weinstock MA, Coulter S, Bates J, Bogaars HA, Larson PI, Burmer GC: Human papillomavirus and widespread cutaneous carcinoma after PUVA photochemotherapy. Arch Dermatol 131:701-704, 1995
40. Young AR: Photocarcinogenecity of psoralens used in PUVA treatment: present status in mouse and man. J Photochem Photobiol B Biol 6:237-247, 1990